Stock Comparison · Live Data
JNJ vs PFE
Side-by-side comparison of Johnson & Johnson (JNJ), Pfizer Inc. (PFE) — live price, market cap, day change, and sector classification.
JNJ vs PFE — which stock is the better buy?
Johnson & Johnson (JNJ) leads this comparison by market capitalization at $546.90B. PFE is today's top mover with a +0.21% move, while PFE sees the highest trading volume at 17.78M shares.
Whether JNJ vs PFE is the better investment for your portfolio depends on your time horizon, risk tolerance, and existing exposure. ArbibX runs Claude AI across thousands of US stocks daily and surfaces the most actionable picks with confidence scores and target prices. For a personalized analysis on JNJ vs PFE, use the in-app "Ask Claude" assistant — it sees the live prices from this page plus your portfolio context.
Per-stock breakdown
- JNJ — Johnson & Johnson trades at $224.41, day change -1.22%, pharmaceutical preparations sector, market cap $546.90B.
- PFE — Pfizer Inc. trades at $26.39, day change +0.21%, pharmaceutical preparations sector, market cap $149.77B.
Frequently asked
Which is the better stock — JNJ vs PFE?
It depends on your goals. Johnson & Johnson (JNJ) has the larger market cap at $546.90B. Today PFE is the strongest performer (+0.21%). For a qualitative read on each name use the AI Top 15 tab on ArbibX.
What is the current price of JNJ and PFE?
JNJ is trading at $224.41 (-1.22% on the day). PFE is trading at $26.39 (+0.21% on the day). Live prices update every minute on the ArbibX terminal.
How does ArbibX compare stocks?
ArbibX pulls live snapshot data from Polygon.io and pairs it with Claude-powered AI analysis. Comparison pages show price, market cap, day change, sector, and key technicals side by side. The deeper analysis (target prices, signals, risk notes) lives on each ticker's dedicated page.
Not financial advice · For informational purposes only · Data via Polygon.io